CDER’s Emerging Drug Safety Technology Meeting Program

https://www.fda.gov/drugs/cder-conversations/cders-emerging-drug-safety-technology-meeting-program?utm_medium=email&utm_source=govdelivery CDER Conversation: Emerging Drug Safety Technology Meeting Program In this CDER Conversation, Robert Ball, M.D., M.P.H., ScM, Deputy Director of CDER’s Office of Surveillance and Epidemiology, explains the Emerging Technology Meeting program and the application of artificial intelligence (AI) in pharmacovigilance (PV) based on his experience of more than a decade researching and developing AI systems in PV.